Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance

Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance

Abstract Monoclonal gammopathy of undetermined significance (MGUS) is a benign hematological condition with the potential to progress to malignant conditions including multiple myeloma and Waldenstrom macroglobulinemia. Medications that modify progression risk have yet to be identified. To investiga...

Full description

Bibliographic Details
Main Authors: Alexander J. Ryu, Shaji Kumar, Angela Dispenzieri, Robert A. Kyle, S. Vincent Rajkumar, Thomas C. Kingsley
Format: Article
Language:English
Published: Nature Publishing Group 2023-02-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00798-7

Internet

https://doi.org/10.1038/s41408-023-00798-7

Similar Items